Hospira Recalls Diazepam Injection Due to Crystallized Active Ingredient
Hospira Inc. is recalling 373,850 tubes of Diazepam Injection USP 10mg/2mL because the product contains particulate identified as crystallized active ingredient.
- Product
- DIAZEPAM — DIAZEPAM (DIAZEPAM)
- Category
- Drug
- Distribution
- Distributed nationwide